Nicholas C. Smith
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nicholas C. Smith
Alto Neuroscience, Inc. reported in an 8-K filed August 27, 2026 that Nicholas C. Smith was appointed President and Chief Financial Officer, effective August 26, 2026.
“On August 26, 2026 (the "Effective Date"), the Board of Directors (the "Board") of Alto Neuroscience, Inc. (the "Company") promoted Nicholas C. Smith, the Company's Chief Financial Officer and Chief Business Officer, to the position of President and Chief Financial Officer, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Alto Neuroscience, Inc. (ANRO)
SEC 8-K
Current2026-08-26–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Alto Neuroscience, Inc.
Other people whose current roles at this company are on record from its filings.
- Amit Etkin CEO, Board Member
- Nicholas Smith CFO
- Michael Hanley COO
- Andrew Dreyfus Board Member
- Andrew Miller, Ph.D. Board Member
- Christopher Nixon Cox Board Member
- Gwill York Board Member
- Husseini Manji Board Member
- Maha Radhakrishnan, M.D. Board Member
- Ramiro (Raymond) Sanchez, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.